Condition: Hypertension · Sponsor: Ionis Pharmaceuticals, Inc.
The purpose of this study was to evaluate the effect of IONIS-AGT-LRx compared to placebo on seated automated office systolic blood pressure (SBP) from baseline to Study Day 85 in uncontrolled hypertensive participants on ≥ 3 antihypertensive medications and to evaluate the effect of IONIS-AGT-LRx on ambulatory blood pressure, seated automated office SBP, seated automated office diastolic blood pressure (DBP), and plasma angiotensinogen (AGT) at each scheduled visit in uncontrolled hypertensive participants on ≥ 3 antihypertensive medications.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Pinnacle Research Group | Anniston, Alabama, United States | — |
| Central Research Associates, Inc. | Birmingham, Alabama, United States | — |
| Achieve Clinical Research, LLC | Birmingham, Alabama, United States | — |
| Cahaba Research, Inc. | Pelham, Alabama, United States | — |
| Syed Research Consultants LLC | Sheffield, Alabama, United States | — |
| Cardiology and Medicine Clinic | Little Rock, Arkansas, United States | — |
| Advanced Research Center | Anaheim, California, United States | — |
| National Research Institute - Huntington Park | Huntington Park, California, United States | — |
| RESPIRE Research | La Mesa, California, United States | — |
| Clinical Trials Research | Lincoln, California, United States | — |
| Catalina Research Institute | Montclair, California, United States | — |
| San Fernando Valley Health Institute | Van Nuys, California, United States | — |
+ 38 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.